Translate
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
SpanishCellares
Fast Facts
Location: Bridgewater
Industry: Life Sciences
Country of Origin: USA
Facility Type: Smart Factory
Cellares, a cutting-edge cell therapy company based in the San Francisco area, expanded its operations by opening a state-of-the-art 118,000-square-foot manufacturing facility in Bridgewater, New Jersey. The company chose New Jersey for its renowned life sciences sector and access to a highly educated workforce. With New Jersey’s deep-rooted history in pharmaceuticals and biotechnology, Cellares is well-positioned to thrive in an ecosystem that fosters innovation and supports advanced therapeutic solutions.
The move to New Jersey also offers Cellares logistical advantages, including a robust infrastructure and proximity to a large consumer base. The new facility provides ample room for growth in turn-key spaces designed to meet the company’s current and future manufacturing needs. By establishing a presence in New Jersey, Cellares can leverage the state’s resources to scale its operations and continue developing life-saving therapies for patients around the world. This strategic expansion highlights New Jersey’s appeal as a hub for life sciences and advanced manufacturing.
“Everyone’s been very welcoming, very supportive. We appreciate the support that we are getting from the local community. New Jersey is known for biopharmaceutical manufacturing. We fit right in. New Jersey and Bridgewater, in particular, they are used to biopharmaceutical manufacturers setting up shop there. So, it’s not like we have to do a lot of explaining.
Fabian Gerlinghaus, CEO and co-founder
Cellares
Fabian Gerlinghaus, CEO and co-founder
Cellares